Skip to main content
. 2024 Nov 13;11(4):691–700. doi: 10.1007/s40801-024-00465-8

Table 4.

BZs induced seizure related AEs

Case (n) No case (n) Total % ROR 95%CI
All 4653 883,051 887,704 0.52
Eszopiclone 4 273 277 1.44 2.78 1.036–7.469
Zopiclone 8 907 915 0.87 1.68 0.835–3.362
Zolpidem 21 2725 2746 0.76 1.46 0.952–2.252
Triazolam 11 847 858 1.28 2.47 1.361–4.477
Brotizolam 24 1623 1647 1.46 2.82 1.880–4.218
Rilmazafone 0 121 121 0.00 0.00
Lormetazepam 2 155 157 1.27 2.45 0.607–9.885
Estazolam 1 360 361 0.28 0.53 0.074–3.753
Nitrazepam 19 2479 2498 0.76 1.46 0.927–2.289
Flunitrazepam 13 2012 2025 0.64 1.23 0.711–2.118
Quazepam 3 240 243 1.23 2.37 0.760–7.413
Haloxazolam 0 3 3 0.00 0.00
Flurazepam 0 22 22 0.00 0.00
Etizolam 40 2253 2293 1.74 3.39 2.476–4.640
Clotiazepam 19 358 377 5.04 10.11 6.367–16.051
Flutazolam 0 11 11 0.00 0.00
Alprazolam 8 635 643 1.24 2.39 1.191–4.810
Bromazepam 10 1088 1098 0.91 1.75 0.936–3.256
Lorazepam 4 626 630 0.63 1.21 0.454–3.243
Diazepam 13 1107 1120 1.16 2.23 1.291–3.859
Cloxazolam 1 105 106 0.94 1.81 0.252–12.956
Fludiazepam 4 13 17 23.53 58.44 19.049–179.308

BZs, benzodiazepines; ROR, reporting odds ratio; 95%CI, 95% confidence interval; NA, not available